Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Control group:EGFR-TKI+Yiqi Yangyin placebo
2 trials
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine
Conditions
Non-small cell lung cancer
Phase 3
A randomized controlled, double-blind study of Chinese medicine combined with EGFR-TKI in the treatment of stage IV EGFR mutation-positive non-small cell lung cancer
Active, not recruiting
ITMCTR1900002685
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine
Non-small cell lung cancer
Start: 2019-12-02
Updated: 2023-02-20
Unknown Phase
A randomized controlled, double-blind study of Chinese medicine combined with EGFR-TKI in the treatment of stage IV EGFR mutation-positive non-small cell lung cancer
Recruiting
ChiCTR1900026748
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine
Non-small cell lung cancer
Start: 2019-12-02
Updated: 2021-06-07